Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H29I2NO3 |
Molecular Weight | 645.3116 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C3=C(O1)C=CC=C3
InChI
InChIKey=IYIKLHRQXLHMJQ-UHFFFAOYSA-N
InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3
Molecular Formula | C25H29I2NO3 |
Molecular Weight | 645.3116 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:25:00 UTC 2023
by
admin
on
Fri Dec 15 15:25:00 UTC 2023
|
Record UNII |
N3RQ532IUT
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
UCSF-FDA TRANSPORTAL |
AMIODARONE
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
WHO-VATC |
QC01BD01
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
FDA ORPHAN DRUG |
70292
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
NDF-RT |
N0000175426
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
12.2
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
NCI_THESAURUS |
C93038
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
LIVERTOX |
NBK548109
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
||
|
WHO-ATC |
C01BD01
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000089825
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
DTXSID7022592
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
2566
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
N0000182141
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inhibitors [MoA] | ||
|
D000638
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
DB01118
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
N3RQ532IUT
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
703
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | RxNorm | ||
|
217-772-1
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
AMIODARONE
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
176
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
N0000182138
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | Cytochrome P450 1A2 Inhibitors [MoA] | ||
|
1951-25-3
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
SUB05451MIG
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
2157
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
C62002
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
N0000185503
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | P-Glycoprotein Inhibitors [MoA] | ||
|
N3RQ532IUT
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
2663
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
CHEMBL633
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
N0000185504
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inhibitors [MoA] | ||
|
m1748
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | Merck Index | ||
|
N0000182137
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | Cytochrome P450 2D6 Inhibitors [MoA] | ||
|
Amiodarone
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY | |||
|
2012
Created by
admin on Fri Dec 15 15:25:00 UTC 2023 , Edited by admin on Fri Dec 15 15:25:00 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> INHIBITOR |
BINDING
IC50
|
||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
ACTIVE AT HIGH CONCENTRATIONS; AMIODARONE CONCENTRATES IN THE LIVER
MAJOR
|
||
|
METABOLIC ENZYME -> INHIBITOR |
POTENT
|
||
|
TARGET -> INHIBITOR |
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE ACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
||
|
METABOLITE -> PARENT |
MAJOR
BILE
|
||
|
METABOLITE -> PARENT |
BILE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||